HELEN DO: Open Payments
NPI 1386034296 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 37 payments from 19 companies in 2025. Trend: 2023 $1,051 · 2024 $1,076 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $325 |
| Dexcom, Inc. | 1 | $80 |
| Lilly USA, LLC | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Insulet Corporation | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Intra-Sana Laboratories | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: EVENITY, OTEZLA, Dexcom G6 Transmitter, JARDIANCE, REPATHA, Omnipod, MOUNJARO, LINZESS.
Industry payments across CA — which companies pay providers there.
